Skip to main content
. 2017 Feb 1;13(2):171–177. doi: 10.1007/s11420-016-9537-1

Table 1.

Baseline and end of study parameters for entire patient population

Baseline
Mean (std.)
End of Treatment
Mean (std.)
p value*
Age (years) 62.62 (8.53) 64.62 N/A
Male (%) 10.26% 10.26% N/A
BMI 22.42 (4.00) 22.11 (8.07) 0.47
sBMD_LS (g/cm2) 0.83 (0.16) 0.91 (0.20) <0.001
T score-LS −2.63 (1.38) −1.98 (1.68) <0.001
sBMD-FN (g/cm2) 0.67 (0.11) 0.70 (0.11) <0.001
sBMD-TH (g/cm2) 0.73 (0.11) 0.75 (0.10) <0.001
25OHD (ng/Ml) 38.37 (11.40) 41.10 (10.23) 0.29
Serum Ca (mg/dL) 9.73 (0.47) 9.61 (0.45) 0.14
NTx (Nm BCE/Mm Cr) 37.04 (33.94) 46.75 (26.69) 0.048
BSAP (units/L) 14.95 (8.75) 20.04 (11.21) 0.08